Navigation Links
World's First Implantation of SPR™ System for Chronic Pain

CLEVELAND, Oct. 20, 2011 /PRNewswire-USNewswire/ -- A 76-year-old man suffering from agonizing post-stroke shoulder pain for more than ten years is now pain-free, thanks to the world's first implantation of an investigational pain therapy device from SPR™ Therapeutics.


The implant was placed at Carolinas Medical Center and the patient was treated at Carolinas Rehabilitation in Charlotte, North Carolina as part of a multi-center clinical study for the treatment of post-stroke shoulder pain sponsored by NDI Medical, LLC, also involving MossRehab in Philadelphia, Weill Cornell Medical Center in New York City, and MetroHealth Medical Center in Cleveland.

"This is the first promising pain treatment technology designed to reduce or eliminate the excruciating shoulder pain that many stroke survivors suffer from," said Dr. Vu Q.C. Nguyen, MD, Director of Stroke Rehabilitation at Carolinas Rehabilitation and principal investigator of the clinical study. "This study will enable us to evaluate whether this advanced technology has come up to the level to meet our patients' needs."

The study participant was given SPR's short-term, temporary therapy in September 2010 which significantly reduced his pain after just a few weeks.  In December 2011, Dr. William Bock, M.D., cardiologist at Carolinas Medical Center then implanted SPR's fully implantable device in the patient, who was pain-free within a few weeks of this surgery.  He has been pain-free since then, except for a short period in February through April 2011 when the system was turned off due to an unrelated illness. Within a few weeks of the system being turned back on, the patient's shoulder pain was completely eliminated.  

The patient's overall quality of life has also improved, including improvements in his sleep, mood, and relationships with others, according to study measures. The clinical study is evaluating the safety and effectiveness of this fully implantable therapy in a group of subjects with post-stroke shoulder pain, and the results experienced by the first subject are very encouraging.

Shoulder pain is a common complication following stroke, affecting almost one third of stroke survivors. Yet, post-stroke shoulder pain has not been adequately addressed by traditional treatment options such as local injections, oral analgesics, physical and occupational therapies, acupuncture, and surface neuromuscular electrical stimulation.

The investigational SPR™ System uses a proprietary method of Intramuscular Nerve (IMN™) Therapy which stimulates peripheral nerves within muscle to treat pain, and is being studied in patients who are unresponsive to or cannot tolerate these conventional therapies.  There are risks associated with participating in the study and receiving the SPR System, and study subjects are informed of all the potential risks before enrolling in the study.

"The implantation of our first fully implantable SPR System for chronic pain is a significant milestone for the treatment of post-stroke shoulder pain and potentially other pain indications in the future," said Maria Bennett, MS, President and CEO of SPR™ Therapeutics. "Relief of shoulder pain is critical in improving these patients' lives."

SPR Therapeutics has developed the SPR System (an investigational device that is limited by U.S. law to investigational use): a two-stage system for the treatment of chronic pain, using the Smartpatch™ short-term system in the first stage, and a fully implantable Micropulse® long-term implant system in its second stage.  The System is non-narcotic and reversible, lead placement in muscle is minimally invasive and visual muscle activation confirms target lead location without imaging.

The SPR System could "potentially revolutionize the treatment of chronic shoulder pain," according to Dr. John Chae, MD, MS, SPR™ Therapeutics' chief medical advisor and professor of Physical Medicine and Rehabilitation at Case Western Reserve University and MetroHealth Medical Center. "Additional studies are being initiated to evaluate this therapy in subjects with shoulder pain that is not related to stroke."

About SPR™ Therapeutics
SPR™ Therapeutics (Stimulation for Pain Relief) is a medical device company that is commercializing pain treatments utilizing its proprietary peripheral nerve stimulation devices. SPR™ Therapeutics was formed in January 2010 as a portfolio company of NDI Medical, LLC, a leading venture capital and commercialization firm that focuses on innovative neurodevice technologies to address significant unmet health conditions. For more information, visit

About Carolinas Rehabilitation
Founded in 1950, Carolinas Rehabilitation has 192 rehabilitation beds, including 90 at the main Carolinas Rehabilitation facility, located on the campus of Carolinas Medical Center.  The total also includes 39 beds at CMC-Mercy, 40 beds at Carolinas Rehabilitation - Mount Holly, 10 beds at Stanly Regional Medical Center and 13 pediatric beds at Levine Children's Hospital.  Carolinas Rehabilitation also has eleven outpatient rehabilitation locations.  

SOURCE SPR Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
2. The Virginia Dental Association Honors Henry Schein Cares With the Organizations First Corporate Partner Award
3. InaVein, LLC Announces First Peer-reviewed Publication of TRIVEX® Used In-Office
4. Cardica to Announce Fiscal 2012 First Quarter Financial Results on Thursday, October 27, 2011
5. DIFICID™ Demonstrated Early Superiority in the First 12 Days Compared to Vancomycin in New Analysis of Phase 3 Study Results
6. Pacira Pharmaceuticals, Inc. Announces New Data Demonstrating Longer Time to First Opioid Use and Reduction in Opioid-Related Adverse Events With EXPAREL™ Compared to Bupivacaine HCl
7. Varian Medical Systems Publishes First Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements
8. National Institute of Cancer Is the First Center in Mexico to Offer Positron Emission Mammography
9. First Results From Ongoing Phase III Trial Show Malaria Vaccine Candidate, RTS,S* Reduces the Risk of Malaria by Half in African Children Aged 5 to 17 Months
10. Alquest Announced as MedNet Solutions First iMedNet CRO Partner
11. HipSextant™ Navigation System Receives Its First Commercial Use
Post Your Comments:
(Date:6/26/2016)... June 26, 2016 One of Australia,s ... the formation of a new biotechnology company, Noxopharm Limited [ABN 50 ... an IPO and to list on the ASX. Noxopharm ... ready to enter a Phase 1 clinical study later this year. ... address one of the biggest problems facing cancer patients - the ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... The ... OSHA Training Institute Education Center headquartered in Northern California, has issued an important ... heat at their worksites. Employers with workers exposed to high temperatures should ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice ... X users can now reveal the media of their split screens with growing ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... today its affiliation with Tennessee Counseling Association. This new relationship allows ... the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/27/2016)... Brooklyn, NY (PRWEB) , ... June 27, 2016 ... ... is using cutting edge technology to revolutionize the emergency ambulance transport experience for ... Many are aware of how Uber has disrupted the taxi industry through the ...
Breaking Medicine News(10 mins):